The Biotech Growth Trust (LON:BIOG) Posts Quarterly Earnings Results

The Biotech Growth Trust (LON:BIOG) announced its earnings results on Wednesday. The company reported GBX (1.90) earnings per share for the quarter, Digital Look Earnings reports. The business had revenue of GBX 43 million for the quarter. The Biotech Growth Trust had a net margin of 140.73% and a negative return on equity of 8.91%.

The Biotech Growth Trust Stock Up 0.5%

Shares of BIOG stock opened at GBX 1,238.32 on Thursday. The Biotech Growth Trust has a 12 month low of GBX 701.63 and a 12 month high of GBX 1,374. The firm has a market cap of £242.72 million, a PE ratio of -86.60 and a beta of 0.60. The stock has a 50 day moving average of GBX 1,292.20 and a 200-day moving average of GBX 1,250.23.

The Biotech Growth Trust Company Profile

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).